Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzalkonium Chloride Solution for Oral Bacterial Clearance
NCT02594449Phase 4Unknown
- Sponsor
- Lustre Pharmaceutical Private Limited
- Start
- Oct 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of benzalkonium chloride in bacterial colonization (3 arms), sponsored by Lustre Pharmaceutical Private Limited. Primary endpoint: The changes of aerobic bacterial colonization in oropharyngeal at 24 hours. Status: unknown.
02
Drugs
benzalkonium chloride
03
Conditions
bacterial colonization
Beyond the preview
Go deeper on NCT02594449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02594449.